Search the Newsroom
Filter By
News Type
Showing 21 - 30 of 233 results
Children’s Hospital of Philadelphia Researchers Reveal New Hope for Chemotherapy-Resistant Neuroblastoma Patients
Researchers at Children’s Hospital of Philadelphia (CHOP) announced a significant breakthrough in understanding chemotherapy resistance in high-risk neuroblastoma, a common and potentially deadly childhood cancer arising within the peripheral nervous system.
Dr. David Teachey appointed Chair of Acute Lymphoblastic Leukemia Disease Committee in the Children’s Oncology Group
Dr. David Teachey, attending physician and Distinguished Endowed Chair in the Department of Pediatrics at Children’s Hospital of Philadelphia (CHOP), has been appointed Chair of the Acute Lymphoblastic Leukemia (ALL) Disease Committee in the Children’s Oncology Group (COG).
Children’s Hospital of Philadelphia Study Reveals Novel Immune-Based Biomarker Helps Detect Ovarian Cancer Two to Four Years Before Conventional Diagnosis
Researchers at Children’s Hospital of Philadelphia (CHOP) announced the discovery of a novel immune-based biomarker that could pave the way for potential lifesaving early detection of high-grade ovarian cancer (HGOC). The findings were published today in the journal Cell Reports Medicine.
Dr. John Maris Presented with the Alex’s Lemonade Stand 2024 Pitcher of Hope Award
John Maris, MD, the Giulio D’Angio Endowed Chair in Neuroblastoma Research at CHOP, is this year’s recipient of the Alex’s Lemonade Stand Pitcher of Hope Award.
Researchers Develop New Tool for Better Classification of Inherited Disease-Causing Variants
Tool is freely available for researchers and conforms to evolving research guidelines
Children’s Hospital of Philadelphia and Sidra Medicine to Establish First-Ever Pediatric Bone Marrow Transplant Program in Qatar
CHOP announced it has entered into a Memorandum of Understanding (MOU) with Sidra Medicine, a specialty healthcare organization for women, children and young people in Qatar.
Researchers Publish Final Results of Key Clinical Trial for Gene Therapy for Sickle Cell Disease
In a landmark study, an international consortium led by researchers at CHOP published the final results of a key clinical trial of the gene therapy CASGEVY for the treatment of sickle cell disease.
International Team Led by CHOP Cancer Expert Receives Multimillion Dollar Grant for Childhood Cancer Research from Cancer Grand Challenges
Dr. Yael Mossé receives recognition for project dedicated to researching and potentially developing new therapies for undruggable solid tumors.
CHOP Experts Showcase Frontier Program at Arab Health Exhibition
Showcasing its longstanding partnership with the United Arab Emirates Health Services, CHOP will exhibit thought-leading clinical research in the EHS booth at the Arab Health 2024 Exhibition and Congress in Dubai.
CHOP's John M. Maris MD, and Penn Medicine's E. John Wherry named 2024 Fellows of the AACR Academy
Distinguished pediatric oncologist John M. Maris, MD, has been named a member of the 2024 class of fellows of the American Association for Cancer Research (AACR) Academy. Each year, the AACR Academy recognizes and honors esteemed scientists whose major contributions have propelled significant innovation and progress against cancer.